Our results clearly demonstrated that the HA-quaternary polyplexes could effectively deliver AMPKα1 shRNA to CRC cells in vivo and that downregulation of the expression of AMPKα1 could significantly inhibit tumor growth in subcutaneous CRC models. This evidence concerns the gene PRKAA1 and neoplasm.